Cancer

Items 1841-1850 of 2192

per page
Set Descending Direction
  1. Progranulin (rat) (rec.) (untagged)
    AG-40A-0196Y
    AG-40A-0196Y-C01010 µg
    CHF 220.00
    AG-40A-0196Y-C05050 µg
    CHF 520.00
    Deglycosylation of rat progranulin. To examine the deglycosylation of rat progranulin, 1μg of rat progranulin is denatured with 1X glycoprotein denaturing buffer at 100°C for 10 minutes. After the addition of NP-40 and G7 reaction buffer, twofol
  2. Progranulin (rat) ELISA Kit
    AG-45A-0043Y
    AG-45A-0043YEK-KI0196 wells
    CHF 620.00
    AG-45A-0043YTP-KI012 x 96 wells
    CHF 1'100.00
    Progranulin (rat) ELISA Kit
  3. Propionyl-L-carnitine . hydrochloride
    CAS  119793-66-7
    AG-CR1-3595
    AG-CR1-3595-M02525 mg
    CHF 80.00
    AG-CR1-3595-M100100 mg
    CHF 170.00
    AG-CR1-3595-M500500 mg
    CHF 490.00
    Propionyl-L-carnitine . hydrochloride
  4. Prostaglandin E2
    CAS  363-24-6
    CDX-P0318
    CDX-P0318-M0055 mg
    CHF 81.00
    CDX-P0318-M01010 mg
    CHF 122.00
    CDX-P0318-M02525 mg
    CHF 244.00
    Prostaglandin E2
  5. Prostaglandin E2
    CAS  363-24-6
    AG-CL1-0001
    AG-CL1-0001-M0011 mg
    CHF 35.00
    AG-CL1-0001-M0055 mg
    CHF 100.00
    Prostaglandin E2
  6. Protodioscin
    CAS  55056-80-9
    CDX-P0451
    CDX-P0451-M01010 mg
    CHF 102.00
    Protodioscin
  7. Pseudolaric acid B
    CAS  82508-31-4
    CDX-P0453
    CDX-P0453-M0011 mg
    CHF 81.00
    CDX-P0453-M01010 mg
    CHF 373.00
    Pseudolaric acid B
  8. Pseudolaric acid B
    CAS  82508-31-4
    AG-CN2-0083
    AG-CN2-0083-C100100 µg
    CHF 30.00
    AG-CN2-0083-M0011 mg
    CHF 90.00
    Pseudolaric acid B
  9. Pseudouridimycin
    CAS  1566586-52-4
    AG-CN2-0316
    AG-CN2-0316-M0011 mg
    CHF 170.00
    AG-CN2-0316-M0055 mg
    CHF 680.00
    Pseudouridimycin
  10. Pseurotin D
    CAS  77409-68-8
    BVT-0426
    BVT-0426-M0011 mg
    CHF 145.00
    Pseurotin D

Items 1841-1850 of 2192

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.